Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aon's Cost Efficiency Measurement shows integration of medical, pharmacy and behavioral health benefits reduced total care costs by $148 per member per year Additional study by Cigna finds higher savings from integrated care for chronically ill beneficiaries, including more than $11,000 in reduced care costs for those taking specialty drugs for inflammatory conditions BLOOMFIELD, Conn. , Jan. 19, 2023 /PRNewswire/ -- A study released today by Cigna (NYSE: CI), a global health service company, finds that triple integration of medical, pharmacy and behavioral benefits resulted in lower health care costs for employers.

Employers Achieve Lower Costs and Improve Health Engagement With Integrated Benefits, Cigna Study Shows

BLOOMFIELD, Conn. , Jan. 18, 2023 /PRNewswire/ -- Evernorth, the health services business of Cigna Corporation (NYSE: CI), today announced the promotion of Adam Kautzner, PharmD, to president, Express Scripts.

Evernorth Names Adam Kautzner President, Express Scripts

Cigna Corporation is a massive health insurance company with over $190 billion in TTM revenues. With strong cash flow, the company is well set up to tackle any potential obstacles ahead.

Cigna Corporation Is At A Great Entry Price

Recently, Zacks.com users have been paying close attention to Cigna (CI). This makes it worthwhile to examine what the stock has in store.

Investors Heavily Search Cigna Corporation (CI): Here is What You Need to Know

Advance Auto Parts

Broadcom

Carlisle Companies

Coterra Energy

Deere & Company

EOG Resources

Invitation Homes

Lennar

Lowe's

Pool

T. Rowe Price Group

Taiwan Semiconductor Manufacturing

Zoetis

This article will focus on DGI stocks that are likely to provide a high rate of dividend growth rather than a high current yield. High-growth dividend stocks are particularly suited for folks who are in the accumulation phase and are several years away from retirement.

Top 10 Dividend Growth Stocks For January 2023

Elevance Health Inc

Shares of several health insurers rallied in trading on Friday after UnitedHealth Group Inc. UNH, +1.79% reported better-than-expected profit and revenue in the fourth quarter of 2022. Elevance Health Inc.'s ELV, +2.52% stock was up 2.6%, while shares of Cigna Corp. CI, +2.24% gained 2.2%, and shares of CVS Health Corp. CVS, +1.21% , which owns Aetna, were up 1.1%.

Elevance Health, Cigna's stocks gain

BLOOMFIELD, Conn. , Jan. 12, 2023 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) will release its fourth quarter 2022 financial results on Friday, February 3, 2023, and will host a conference call the same day.

Cigna Corporation's Fourth Quarter 2022 Earnings Release Details

2023 Marks the Fourth Year Cigna Named to the JUST 100 BLOOMFIELD, Conn. , Jan. 11, 2023 /PRNewswire/ -- Cigna Corporation (NYSE: CI) today announced it earned the #1 ranking among the health care industry in the newly released list of America's Most JUST Companies by JUST Capital and CNBC.

Cigna Earned the #1 Ranking for Corporate Citizenship in the Health Care Industry by JUST Capital and CNBC

As inflationary pressures continue to mount, I see healthcare as a defensive industry, with the 1Y returns for XLV (-0.04%) being superior to SPY (-17.49%). With their Evernorth platform, Cigna is accelerating vertical integration, moving beyond the traditional financing model for health insurance and focusing on servicing.

Cigna: A Defensive Stock With Multiple Avenues For Growth

Automatic Data Processing

Applied Materials

Franklin Resources

BHP Billiton

Blackstone Group

Boston Properties

Comcast

Costco

Chevron

Digital Realty Trust

Enterprise Products Partners

Johnson & Johnson

LyondellBasell Industries

Altria

Merck

Microsoft

Newmont Mining

NIKE

This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. It's always a good idea to keep your wish list ready by separating the wheat from the chaff.

5 Relatively Safe And Cheap Dividend Stocks To Invest In - January 2023

Cigna (CI) remains well-poised for growth on the back of the solid Evernorth and Cigna Healthcare businesses, an expanding customer base and robust cash-generating abilities.

Here's Why You Should Hold Cigna (CI) Stock in Your Portfolio

Walgreens

CHICAGO & NEW YORK--( BUSINESS WIRE )--VillageMD announced today that on Jan. 3, 2023, it completed the previously disclosed acquisition of Summit Health-CityMD, a leading provider of primary, specialty and urgent care.

VillageMD Finalizes Acquisition of Summit Health-CityMD, Creating One of the Largest Independent Provider Groups in the U.S.

Ball Corp

Best Buy

Domino's Pizza

Mastercard

Monolithic Power Systems

MSCI

SS&C Technologies Hlds

Skyworks Solutions

Tractor Supply

Texas Instruments

Visa

I present my top 15 high-growth dividend stocks to consider during the month of January. The watchlist posted a loss of 5.21% in December and finishes the year with a loss of 8.58%.

My Top 15 High-Growth Dividend Stocks For January 2023

Cigna Corp. CI, -0.34% said Friday that as it meets with investors and analysts over the next several weeks, it plans to affirm its guidance for 2022 adjusted earnings per share of “at least” $23.10. The health insurer provided that guidance on Nov. 3, when it raised its outlook to at least $23.10 from at least $22.90.

Cigna expects to affirm 2022 profit guidance in ‘the next several weeks'

Centene

Humana

UnitedHealth Group

A well-performing government business might aid the Medical-HMO industry. However, expenses incurred for technology advancements and a shortage of nurses will dampen margins.

4 HMO Stocks in Focus Despite Tech Costs, Nursing Shortage

Blue chip healthcare stocks Johnson & Johnson and Cigna are always in season.

2 Mammoth Stocks With Dividends to Buy Before 2022 Ends

BLOOMFIELD, Conn. , Dec. 20, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) announced today that David Cordani, chairman and chief executive officer, will present at the 41st Annual J.P.

Cigna Corporation Announces Appearance at the 41st Annual J.P. Morgan Healthcare Conference

BLOOMFIELD, Conn. , Dec. 19, 2022 /PRNewswire/ -- Cigna Corporation, a global health service company, has been named an industry leader in corporate sustainability for the sixth consecutive year on the Dow Jones Sustainability Indices (DJSI), the most prestigious honor for corporate responsibility and sustainability performances.

Cigna Named Corporate Sustainability Leader by Dow Jones for Sixth Consecutive Year

100% technical buy signals. 13 new highs and up 9.52% in the last month.

Cigna Is Healthy

Cigna's (CI) stock price is increasing on the back of solid performances in the Evernorth and Cigna Healthcare businesses.

Cigna (CI) Hits 52-Week High: What's Driving the Stock?

Caterpillar

Netflix

Workday

Across the market, Cowen & Co. analysts see undervalued stocks.

Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen's favorites for 2023

D.R. Horton

Top 10 Dividend Growth Stocks For December 2022

News for Cigna Stock (CI)